Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Failed Prior Chemotherapy”

41 trials

Showing 20 of 41 results

Testing effectiveness (Phase 2)Study completedNCT00072631
What this trial is testing

Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non Small Cell Lung CancerFailed Prior Chemotherapy
OSI Pharmaceuticals 43
Large-scale testing (Phase 3)Active Not RecruitingNCT04639986
What this trial is testing

Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Gilead Sciences 331
Early research (Phase 1)Study completedNCT00972036
What this trial is testing

Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT01497964
What this trial is testing

Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy

Who this might be right for
Gastric Cancer
Sanofi 16
Testing effectiveness (Phase 2)Study completedNCT00895310
What this trial is testing

Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy

Who this might be right for
Prostate Cancer
University of California, Davis 30
Testing effectiveness (Phase 2)Study completedNCT00109096
What this trial is testing

Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy

Who this might be right for
Ovarian NeoplasmsPrimary Peritoneal Cancer
Eli Lilly and Company 100
Testing effectiveness (Phase 2)Study completedNCT00041249
What this trial is testing

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
European Organisation for Research and Treatment of Cancer - EORTC 64
Not applicableNo Longer AvailableNCT02570412
What this trial is testing

Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

Who this might be right for
Sarcoma
CytRx
Testing effectiveness (Phase 2)Study completedNCT00548093
What this trial is testing

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

Who this might be right for
Carcinoma, Non Small Cell Lung
Pfizer 66
Testing effectiveness (Phase 2)UnknownNCT03213587
What this trial is testing

Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 51
Testing effectiveness (Phase 2)WithdrawnNCT00021489
What this trial is testing

Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00365547
What this trial is testing

Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota 46
Testing effectiveness (Phase 2)Study completedNCT00064350
What this trial is testing

Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group 342
Large-scale testing (Phase 3)Study completedNCT03834519
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 793
Testing effectiveness (Phase 2)UnknownNCT04872634
What this trial is testing

Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment

Who this might be right for
Non-small Cell Lung Cancer
NKMAX Co., Ltd. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06057571
What this trial is testing

Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor

Who this might be right for
Cholangiocarcinoma Metastatic
TransThera Sciences (Nanjing), Inc. 50
Testing effectiveness (Phase 2)UnknownNCT00509964
What this trial is testing

Second-Line Irinotecan vs. ILF for AGC

Who this might be right for
Stomach NeoplasmMetastaticSecond-Line
Gachon University Gil Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT02038933
What this trial is testing

Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)

Who this might be right for
Lymphoma. Non-Hodgkin
Bristol-Myers Squibb 121
Testing effectiveness (Phase 2)UnknownNCT00021008
What this trial is testing

ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00078260
What this trial is testing

A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 589
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation